Taken together, these findings suggest that USP18 blocked sorafenib-induced ferroptosis via deISGylation and degradation of NCOA4, and ultimately confers HCC cells resistance to sorafenib. This evidence concerns the gene USP18 and hepatocellular carcinoma.